Skip to main content

Advertisement

SpringerLink
Log in

Primary creatine deficiency syndrome as a potential missed diagnosis in children with psychomotor delay and seizure: case presentation with two novel variants and literature review

  • Review article
  • Published:
Acta Neurologica Belgica Aims and scope Submit manuscript

Abstract

Creatine is the main source of energy for the brain. Primary creatine deficiency syndromes (PCDSs) are inborn error of metabolism of creatine synthesis. Symptoms of central nervous system involvement are the most common clinical manifestations in these disorders. We reviewed medical records of all genetically confirmed patients diagnosed by whole exome sequencing who were referred to Myelin and Neurodegenerative Disorders Clinic, Children’s Medical Center, Tehran, Iran, from May 2016 to Dec 2018. A literature review was conducted on clinical and genomic variability of PCDS to compare our patients with previously reported cases. We report two patients with creatine deficiency among a cohort of 550 registered cases out of which 200 patients had a genetically confirmed neurodegenerative disorder diagnosis. The main complain in the first patient with creatine transporter (CRTR) deficiency was seizure and genetic study in this patient identified a novel hemizygote variant of “c.92 > T; p.Pro31Leu” in the first exon of SLC6A8 gene. The second patient with guanidinoacetate methyltransferase (GAMT) deficiency had an unknown motor and speech delay as the striking manifestation and molecular assay revealed a novel homozygote variant of “c.134G > A; p.Trp45*” in the first exon of GAMT gene. PCDSs usually are associated with nonspecific neurologic symptoms. The first presented case had a mean delayed diagnosis of 5 years. Therefore, in children with unexplained neurologic features including developmental delay and/or regression, mental disability and repeated seizures without any significant findings in metabolic studies, PCDSs can be considered as a differential diagnosis and molecular analysis can be helpful for the precise diagnosis and treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Cecil KM, Salomons GS, Ball WSJ, Wong B, Chuck G, Verhoeven NM, Jakobs C, DeGrauw TJ (2001) Irreversible brain creatine deficiency with elevated serum and urine creatine: a creatine transporter defect? Ann Neurol 49:401–404

    CAS  PubMed  Google Scholar 

  2. Stockler S, Holzbach U, Hanefeld F et al (1994) Creatine deficiency in the brain: a new, treatable inborn error of metabolism. Pediatr Res 36:409–413

    CAS  PubMed  Google Scholar 

  3. Andres RH, Ducray AD, Schlattner U, Wallimann T, Widmer HR (2008) Functions and effects of creatine in the central nervous system. Brain Res Bull 76:329–343

    CAS  PubMed  Google Scholar 

  4. Thurm A, Himelstein D, DʼSouza P, Rennert O, Jiang S, Olatunji D, Longo N, Pasquali M, Swedo S, Salomons GS, Carrillo N (2016) Creatine transporter deficiency: screening of males with neurodevelopmental disorders and neurocognitive characterization of a case. J Dev Behav Pediatr 37(4):322–326

    PubMed  PubMed Central  Google Scholar 

  5. Valle D, Simell O (2001) The hyperornithinemias. In: Scriver CR, Beaudet A, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw Hill, New York, pp 1857–1896

    Google Scholar 

  6. van de Kamp M, Betsalel OT, Mercimek-Mahmutoglu S, Abulhoul L, Grünewald S, Anselm I, Azzouz H, Bratkovic D et al (2013) Phenotype and genotype in 101 males with X-linked creatine transporter deficiency. J Med Genet 50(7):463–472

    PubMed  Google Scholar 

  7. Stockler-Ipsiroglu S, Mercimek-Mahmutoglu S, Solomons G (2012) Creatine deficiency syndromes. In: Saudubray JM, van den Berghe G, Walter JH (eds) Inborn metabolic diseases, diagnosis and treatment, 5th edn. Springer, New York, pp 239–247

    Google Scholar 

  8. Mercimek-Mahmutoglu S, Connolly MB, Poskitt KJ, Horvath GA, Lowry N, Salomons GS, Casey B, Sinclair G, Davis C, Jakobs C, Stockler-Ipsiroglu S (2010) Treatment of intractable epilepsy in a female with SLC6A8 deficiency. Mol Genet Metab 101(4):409–412

    CAS  PubMed  Google Scholar 

  9. Schulze A, Battini R (2007) Pre-symptomatic treatment of creatine biosynthesis defects. Subcell Biochem 46:167–181

    PubMed  Google Scholar 

  10. Aydin HI (2018) Creatine transporter deficiency in two brothers with autism spectrum disorder. Indian Pediatr 55(1):67–68

    PubMed  Google Scholar 

  11. Chun-Hui Hu, Fan Yu-Ying, Wang Long-Fei, Tao Yu, Wang Xiao-Ming, Wang Hua (2015) Diagnosis of X-linked creatine transporter deficiency in a patient from Northeast China. Neurol Asia 20(2):197–201

    Google Scholar 

  12. Heussinger N, Saake M, Mennecke A, Dörr HG, Trollmann R (2017) Variable white matter atrophy and intellectual development in a family with X-linked creatine transporter deficiency despite genotypic homogeneity. Pediatr Neurol 67:45–52

    PubMed  Google Scholar 

  13. van de Kamp JM, Errami A, Howidi M, Anselm I, Winter S, Phalin-Roque J, Osaka H, van Dooren SJM, Mancini GM, Steinberg SJ, Salomons GS (2014) Genotype–phenotype correlation of contiguous gene deletions of SLC6A8, BCAP31 and ABCD1. Clin Genet 87(2):141–147

    PubMed  Google Scholar 

  14. Kato H, Miyake F, Shimbo H, Ohya M, Sugawara H, Aida N, Anzai R, Takagi M, Okuda M, Takano K, Wada T, Iai M, Yamashita S, Osaka H (2014) Urine screening for patients with developmental disabilities detected a patient with creatine transporter deficiency due to a novel missense mutation in SLC6A8. Brain Dev 36(7):630–633

    PubMed  Google Scholar 

  15. Nozaki F, Kumada T, Shibata M, Fujii T, Wada T, Osaka H (2015) A family with creatine transporter deficiency diagnosed with urinary creatine/creatinine ratio and the family history: the third Japanese familial case. No to Hattatsu 47(1):49–52

    PubMed  Google Scholar 

  16. Ardon O, Procter M, Maoab R, Longo N, Landau YE, ShilonHadass A, Gabis LV, Hoffmann C, Tzadok M, Heimerd G, Sadac S, Ben-Zeev B, Aniksterd Y (2016) Creatine transporter deficiency: novel mutations and functional studies. Mol Genet Metab Rep 30(8):20–23

    Google Scholar 

  17. Dreha-Kulaczewski S, Kalscheuer V, Tzschach A, Hu H, Helms G, Brockmann K, Weddige A (2014) A novel SLC6A8 mutation in a large family with x-linked intellectual disability: clinical and proton magnetic resonance spectroscopy data of both hemizygous males and heterozygous females. JIMD Rep 13:91–99

    CAS  PubMed  Google Scholar 

  18. Nash SR, Giros B, Kingsmore SF et al (1994) Cloning, pharmacological characterization, and genomic localization of the human creatine transporter. Recept Channels 2(2):165–174

    CAS  PubMed  Google Scholar 

  19. Aydin Halil Ibrahim, Mujgan Sonmez F (2017) A novel mutation in guanidinoacetate methyltransferase (GAMT) deficiency in two patients associated with epilepsy, developmental delay, hyperactivity, autistic behavior. Eur J Paediatr Neurol 21:123–140

    Google Scholar 

  20. Pacheva I, Ivanov I, Penkov M, Kancheva D, Jordanova A, Ivanova M (2016) Creatine deficiency syndrome could be missed easily: a case report of guanidinoacetate methyltransferase deficiency presented with neurodevelopmental delay, seizures, and behavioral changes, but normal structural MRI. Ann Clin Lab Sci 46(5):557–561

    PubMed  Google Scholar 

  21. Stern WM, Winston JS, Murphy E, Cross JH, Sander JW (2017) Guanidinoacetate methyltransferase (GAMT) deficiency: rare but treatable epilepsy. Pract Neurol 17(3):207–211

    PubMed  Google Scholar 

  22. Stockler-Ipsiroglu S, van Karnebeek C, Longo N, Korenke GC, Mercimek-Mahmutoglu S, Marquart I, Barshop B et al (2014) Guanidinoacetate methyltransferase (GAMT) deficiency: outcomes in 48 individuals and recommendations for diagnosis, treatment and monitoring. Mol Genet Metab J 111(1):16–25

    CAS  Google Scholar 

  23. Sun W, Wang Y, Zu Z, Jiang Y, Lu W, Wang H, Wu B, Zhang P, Peng X, Zhou H (2017) First reported Chinese case of guanidinoacetate methyltransferase deficiency in a 4-year old child. Clin Chim Acta 470:42–45

    CAS  PubMed  Google Scholar 

  24. Khaikin Yannay, Sidky Sarah, Anastasi Jose Abdenur Arnaud, Ballhausen Diana et al (2018) Treatment outcome of twenty-two patients with guanidinoacetate methyltransferase deficiency: an international retrospective cohort study. Eur J Pediatr Neurol 22(3):369–379

    Google Scholar 

  25. Braissant O, Henry H (2008) AGAT, GAMT and SLC6A8 distribution in the central nervous system, in relation to creatine deficiency syndromes: a review. J Inherit Metab Dis 31:230–239

    CAS  PubMed  Google Scholar 

  26. Nouioua S, Cheillan D, Zaouidi S, Salomons GS, Amedjout N, Kessaci F, Boulahdour N, Hamadouche T, Tazir M (2013) Creatine deficiency syndrome. A treatable myopathy due to arginine-glycine amidinotransferase (AGAT) deficiency. Neuromuscul Disord 23:670–674

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Pediatric Endocrinology and Metabolism, Growth and Development Research Center, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran

    Parastoo Rostami

  2. Myelin Disorders Clinic (Iranian Neurometabolic Registry), Pediatric Neurology Division, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran

    Sareh Hosseinpour, Mahmoud Reza Ashrafi & Ali Reza Tavasoli

  3. Division of Pediatric Radiology, Department of Pediatrics, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran

    Houman Alizadeh

  4. Department of Medical Genetics, Faculty of Medical Sciences, Tarbiat Modares University, Teheran, Iran

    Masoud Garshasbi

Authors
  1. Parastoo Rostami
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sareh Hosseinpour
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mahmoud Reza Ashrafi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Houman Alizadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Masoud Garshasbi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ali Reza Tavasoli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Masoud Garshasbi or Ali Reza Tavasoli.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rostami, P., Hosseinpour, S., Ashrafi, M.R. et al. Primary creatine deficiency syndrome as a potential missed diagnosis in children with psychomotor delay and seizure: case presentation with two novel variants and literature review. Acta Neurol Belg 120, 511–516 (2020). https://doi.org/10.1007/s13760-019-01168-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13760-019-01168-6

Keywords

Search

Navigation